KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Intangibles (2016 - 2025)

Historic Intangibles for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $25.5 billion.

  • Cvs Health's Intangibles fell 664.28% to $25.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $25.5 billion, marking a year-over-year decrease of 664.28%. This contributed to the annual value of $25.5 billion for FY2025, which is 664.28% down from last year.
  • Latest data reveals that Cvs Health reported Intangibles of $25.5 billion as of Q4 2025, which was down 664.28% from $26.0 billion recorded in Q3 2025.
  • Cvs Health's Intangibles' 5-year high stood at $30.6 billion during Q1 2021, with a 5-year trough of $24.8 billion in Q4 2022.
  • Its 5-year average for Intangibles is $27.9 billion, with a median of $28.2 billion in 2022.
  • In the last 5 years, Cvs Health's Intangibles tumbled by 1485.19% in 2022 and then surged by 1786.48% in 2023.
  • Over the past 5 years, Cvs Health's Intangibles (Quarter) stood at $29.0 billion in 2021, then dropped by 14.55% to $24.8 billion in 2022, then increased by 17.86% to $29.2 billion in 2023, then dropped by 6.54% to $27.3 billion in 2024, then dropped by 6.64% to $25.5 billion in 2025.
  • Its last three reported values are $25.5 billion in Q4 2025, $26.0 billion for Q3 2025, and $26.2 billion during Q2 2025.